Onyvax-R

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameOnyvax-R
Drug Alias Namerenal cancer vaccine (Onyvax)
ClassificationCell and gene therapy > Cell therapyVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsKidney Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesOnyvax Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesOnyvax Ltd
Active IndicationsN/A
Inactive IndicationsKidney Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A